Evidence map›Paper›PMID 29078773›Full record

ArticleMalaria journal2017

Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries.

Chris Drakeley, Salim Abdulla, Selidji Todagbe Agnandji, José Francisco Fernandes, Peter Kremsner, Bertrand Lell, Ludovic Mewono, Bache Emmanuel Bache, Michael Gabriel Mihayo, Omar Juma and 40 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Malaria journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01190202 (Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01190202 nacompletednot on this map

Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa

TypeinterventionalSponsorGlaxoSmithKlineRan2011 to 2013Enrolled21,618ConditionsMalaria, Malaria VaccinesArmsBlood sampling, Assessment of body temperature
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 69 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Microscopic and submicroscopic infection byFrontiers in cellular and infection microbiology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

50 authors at 10 institutions in 10 countries.

Chris DrakeleyLondon School of Hygiene and Tropical Medicine, London, UK.
Salim AbdullaIfakara Institute of Health, Bagamoyo Research and Training Centre, Bagamoyo District Hospital, P.O. Box 74, Bagamoyo, Tanzania. sabdulla@ihi.or.tz.ORCID 0000-0001-5071-5205
Selidji Todagbe AgnandjiAlbert Schweitzer Hospital, Lambaréné, Gabon and Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
José Francisco FernandesAlbert Schweitzer Hospital, Lambaréné, Gabon and Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
Peter KremsnerAlbert Schweitzer Hospital, Lambaréné, Gabon and Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
Bertrand LellAlbert Schweitzer Hospital, Lambaréné, Gabon and Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
Ludovic MewonoAlbert Schweitzer Hospital, Lambaréné, Gabon and Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
Bache Emmanuel BacheAlbert Schweitzer Hospital, Lambaréné, Gabon and Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
Michael Gabriel MihayoIfakara Institute of Health, Bagamoyo Research and Training Centre, Bagamoyo District Hospital, P.O. Box 74, Bagamoyo, Tanzania.
Omar JumaIfakara Institute of Health, Bagamoyo Research and Training Centre, Bagamoyo District Hospital, P.O. Box 74, Bagamoyo, Tanzania.
Marcel TannerIfakara Institute of Health, Bagamoyo Research and Training Centre, Bagamoyo District Hospital, P.O. Box 74, Bagamoyo, Tanzania.
Marc Christian TahitaInstitut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso.
Halidou TintoInstitut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso.
Salou DialloInstitut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso.
Palpouguini LompoInstitut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso.
Umberto D'AlessandroLondon School of Hygiene and Tropical Medicine, London, UK.
Bernhards OgutuKEMRI-Walter Reed Project, Kombewa, Kenya.
Lucas OtienoKEMRI-Walter Reed Project, Kombewa, Kenya.
Solomon OtienoKEMRI-Walter Reed Project, Kombewa, Kenya.
Walter OtienoKEMRI-Walter Reed Project, Kombewa, Kenya.
Janet OyiekoKEMRI-Walter Reed Project, Kombewa, Kenya.
Kwaku Poku AsanteKintampo Health Research Center, Kintampo, Ghana.
Dominic Bon-Ereme DeryKintampo Health Research Center, Kintampo, Ghana.
George AdjeiKintampo Health Research Center, Kintampo, Ghana.
Elisha AdenijiKintampo Health Research Center, Kintampo, Ghana.
Dorcas AtibillaKintampo Health Research Center, Kintampo, Ghana.
Seth Owusu-AgyeiLondon School of Hygiene and Tropical Medicine, London, UK.
Brian GreenwoodLondon School of Hygiene and Tropical Medicine, London, UK.
Samwel GesaseNational Institute for Medical Research, Korogwe, Tanzania.
John LusinguNational Institute for Medical Research, Korogwe, Tanzania.
Coline MahendeNational Institute for Medical Research, Korogwe, Tanzania.
Robert MongiNational Institute for Medical Research, Korogwe, Tanzania.
Method SegejaNational Institute for Medical Research, Korogwe, Tanzania.
Samuel AdjeiKwame Nkrumah University of Science and Technology, Agogo, Ghana.
Tsiri AgbenyegaKwame Nkrumah University of Science and Technology, Agogo, Ghana.
Alex AgyekumKwame Nkrumah University of Science and Technology, Agogo, Ghana.
Daniel AnsongKwame Nkrumah University of Science and Technology, Agogo, Ghana.
John Tanko BawaKwame Nkrumah University of Science and Technology, Agogo, Ghana.
Harry Owusu BoatengKwame Nkrumah University of Science and Technology, Agogo, Ghana.
Léonard DandaloUniversity of North Carolina Project, Lilongwe, Malawi.
Veronica EscamillaUniversity of North Carolina Project, Lilongwe, Malawi.
Irving HoffmanUniversity of North Carolina Project, Lilongwe, Malawi.
Peter MaenjeUniversity of North Carolina Project, Lilongwe, Malawi.
Francis MartinsonUniversity of North Carolina Project, Lilongwe, Malawi.
Terrell CarterThe PATH Malaria Vaccine Initiative, Washington, D.C., USA.
Didier LeboulleuxThe PATH Malaria Vaccine Initiative, Washington, D.C., USA.
David C KaslowThe PATH Malaria Vaccine Initiative, Washington, D.C., USA.
Effua UsufMedical Research Council Unit, The Gambia, Banjul, Gambia.
Jean-Yves PirçonGSK Vaccines, Wavre, Belgium.
Edith Roset BahmanyarGSK Vaccines, Wavre, Belgium.
Albert Schweitzer Hospital · GAKwame Nkrumah University of Science and Technology · GHKintampo Health Research Centre · GHNational Institute for Medical Research · TZIfakara Health Institute · TZInstitut de Recherche en Sciences de la Santé · BFGlaxoSmithKline (Belgium) · BELondon School of Hygiene & Tropical Medicine · GBU.S. President's Malaria Initiative · USMRC Unit the Gambia · GM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPlasmodium falciparum prevalence (PfPR) is a widely used metric for assessing malaria transmission intensity. This study was carried out concurrently with the RTS,S/AS01 candidate malaria vaccine Phase III trial and estimated PfPR over ≤ 4 standardized cross-sectional surveys.

methodsThis epidemiology study (NCT01190202) was conducted in 8 sites from 6 countries (Burkina Faso, Gabon, Ghana, Kenya, Malawi, and Tanzania), between March 2011 and December 2013. Participants were enrolled in a 2:1:1 ratio according to age category: 6 months-4 years, 5-19 years, and ≥ 20 years, respectively, per year and per centre. All sites carried out surveys 1-3 while survey 4 was conducted only in 3 sites. Surveys were usually performed during the peak malaria parasite transmission season, in one home visit, when medical history and malaria risk factors/prevention measures were collected, and a blood sample taken for rapid diagnostic test, microscopy, and haemoglobin measurement. PfPR was estimated by site and age category.

resultsOverall, 6401 (survey 1), 6411 (survey 2), 6400 (survey 3), and 2399 (survey 4) individuals were included in the analyses. In the 6 months-4 years age group, the lowest prevalence (assessed using microscopy) was observed in 2 Tanzanian centres (4.6% for Korogwe and 9.95% for Bagamoyo) and Lambaréné, Gabon (6.0%), while the highest PfPR was recorded for Nanoro, Burkina Faso (52.5%). PfPR significantly decreased over the 3 years in Agogo (Ghana), Kombewa (Kenya), Lilongwe (Malawi), and Bagamoyo (Tanzania), and a trend for increased PfPR was observed over the 4 surveys for Kintampo, Ghana. Over the 4 surveys, for all sites, PfPR was predominantly higher in the 5-19 years group than in the other age categories. Occurrence of fever and anaemia was associated with high P. falciparum parasitaemia. Univariate analyses showed a significant association of anti-malarial treatment in 4 surveys (odds ratios [ORs]: 0.52, 0.52, 0.68, 0.41) and bed net use in 2 surveys (ORs: 0.63, 0.68, 1.03, 1.78) with lower risk of malaria infection.

conclusionLocal PfPR differed substantially between sites and age groups. In children 6 months-4 years old, a significant decrease in prevalence over the 3 years was observed in 4 out of the 8 study sites. Trial registration Clinical Trials.gov identifier: NCT01190202:NCT. GSK Study ID numbers: 114001.

Indexed as

AdolescentAdultAfrica South of the SaharaAgedChildChild, PreschoolCross-Sectional StudiesFemaleHumansInfantMalaria, FalciparumMaleMiddle AgedPlasmodium falciparumPrevalenceYoung AdultAnaemiaEpidemiologyMalariaPlasmodium falciparumPrevalenceTransmission

Identifiers

PMID29078773
PMCPMC5658967
OpenAlexW2765953674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.